An interaction between carbamazepine and fluvoxamine.
作者信息
Martinelli V, Bocchetta A, Palmas A M, Del Zompo M
出版信息
Br J Clin Pharmacol. 1993 Dec;36(6):615-6. doi: 10.1111/j.1365-2125.1993.tb00425.x.
Abstract
摘要
相似文献
1
An interaction between carbamazepine and fluvoxamine.卡马西平与氟伏沙明之间的相互作用。
Br J Clin Pharmacol. 1993 Dec;36(6):615-6. doi: 10.1111/j.1365-2125.1993.tb00425.x.
2
Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
Ann Pharmacother. 2000 Jan;34(1):122-3. doi: 10.1345/aph.19223.
3
[A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(4):53-7.
4
Drug interaction of tizanidine and fluvoxamine.替扎尼定与氟伏沙明的药物相互作用。
Clin Pharmacol Ther. 2004 Nov;76(5):509-10. doi: 10.1016/j.clpt.2004.08.003.
5
Drug interactions with selective serotonin reuptake inhibitors, especially with other psychotropics.药物与选择性5-羟色胺再摄取抑制剂的相互作用，尤其是与其他精神药物的相互作用。
Prescrire Int. 2001 Feb;10(51):25-31.
6
Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration.与托吡酯-氟伏沙明联合用药相关的可逆性震颤和肌阵挛。
Clin Neuropharmacol. 2008 Nov-Dec;31(6):366-7. doi: 10.1097/WNF.0b013e31815ce4c2.
7
[Fluoxetine versus fluvoxamine for treatment of chronic pain].
Minerva Anestesiol. 2000 Jan-Feb;66(1-2):55-61.
8
Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animals.阿立哌唑联合卡马西平和氟伏沙明对实验动物肝功能的影响。
Indian J Pharmacol. 2013 Mar-Apr;45(2):121-5. doi: 10.4103/0253-7613.108280.
9
EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
Pharmacopsychiatry. 2007 May;40(3):129. doi: 10.1055/s-2007-973834.
10
Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.
Int Psychogeriatr. 2006 Dec;18(4):749-51. doi: 10.1017/S1041610206214418.
引用本文的文献
1
Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children.儿童癫痫共患病的药物治疗。
Paediatr Drugs. 2021 Jan;23(1):55-73. doi: 10.1007/s40272-020-00428-w. Epub 2020 Nov 24.
2
Deaths involving contraindicated and inappropriate combinations of serotonergic drugs.涉及禁止和不适当的组合的血清素能药物的死亡。
Int J Legal Med. 2011 Nov;125(6):803-15. doi: 10.1007/s00414-010-0536-3. Epub 2010 Dec 1.
3
Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.综述：细胞色素P450基因多态性对血清素能药物代谢、反应、相互作用及不良反应影响的药物遗传学方面
Forensic Sci Med Pathol. 2011 Jun;7(2):162-84. doi: 10.1007/s12024-010-9188-3. Epub 2010 Nov 4.
4
Clinically significant drug interactions with antidepressants in the elderly.老年人中与抗抑郁药具有临床意义的药物相互作用。
Drugs Aging. 2002;19(4):299-320. doi: 10.2165/00002512-200219040-00004.
5
Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.接受抗惊厥药物治疗患者的合并症治疗：具有临床意义的药物相互作用。
Drug Saf. 1998 Dec;19(6):495-510. doi: 10.2165/00002018-199819060-00006.
6
Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.卡马西平具有临床意义的药代动力学药物相互作用。最新进展。
Clin Pharmacokinet. 1996 Sep;31(3):198-214. doi: 10.2165/00003088-199631030-00004.
7
Fluvoxamine. A review of global drug-drug interaction data.氟伏沙明。全球药物相互作用数据综述。
Clin Pharmacokinet. 1995;29 Suppl 1:26-31; discussion 31-2. doi: 10.2165/00003088-199500291-00006.
8
Clinical pharmacokinetics of fluvoxamine.氟伏沙明的临床药代动力学。
Clin Pharmacokinet. 1994 Sep;27(3):175-90. doi: 10.2165/00003088-199427030-00002.
本文引用的文献
1
Fluvoxamine is a potent inhibitor of cytochrome P4501A2.氟伏沙明是细胞色素P4501A2的强效抑制剂。
Biochem Pharmacol. 1993 Mar 24;45(6):1211-4. doi: 10.1016/0006-2952(93)90272-x.
2
Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity.氟伏沙明，一种新型抗抑郁药物，未表现出抗血清素活性。
Eur J Pharmacol. 1982 Jul 9;81(2):287-92. doi: 10.1016/0014-2999(82)90446-0.
3
Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.氟伏沙明。对其药效学、药代动力学特性及在抑郁症治疗中的疗效的综述。
Drugs. 1986 Oct;32(4):313-34. doi: 10.2165/00003495-198632040-00002.
4
Interaction of fluoxetine with carbamazepine.
J Clin Psychiatry. 1990 Mar;51(3):126.
5
Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up.
J Clin Psychopharmacol. 1990 Oct;10(5):318-27.
6
Fluvoxamine-tricyclic antidepressant interaction. An accidental finding.氟伏沙明与三环类抗抑郁药的相互作用。一项意外发现。
Eur J Clin Pharmacol. 1991;40(1):119-20. doi: 10.1007/BF00315151.
7
Adverse effects and drug interactions associated with fluoxetine therapy.与氟西汀治疗相关的不良反应和药物相互作用。
DICP. 1991 Jun;25(6):657-61. doi: 10.1177/106002809102500617.
8
Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy.一名11岁男孩中氟伏沙明与缓释茶碱之间的毒性相互作用。
Drug Saf. 1991 Nov-Dec;6(6):460-2. doi: 10.2165/00002018-199106060-00006.
9
An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro.卡马西平体外形成细胞毒性、蛋白质反应性和稳定代谢物的研究。
Biochem Pharmacol. 1992 Apr 15;43(8):1675-82. doi: 10.1016/0006-2952(92)90696-g.
10
The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes.酶诱导对小鼠肝微粒体介导的卡马西平细胞色素P450生物活化的影响。
Biochem Pharmacol. 1992 Dec 15;44(12):2307-14. doi: 10.1016/0006-2952(92)90674-8.
Zotero 插件